# Change Control Management Template
## For Healthcare and Pharmaceutical Projects

## Document Control

| Document Information | Details |
|---|---|
| **Document Title** | Change Control Management Template |
| **Document ID** | CCMT-[PROJECT-ID]-[VERSION] |
| **Version** | 1.0 |
| **Effective Date** | [EFFECTIVE DATE] |
| **Next Review Date** | [REVIEW DATE] |
| **Document Owner** | [DOCUMENT OWNER] |
| **Supersedes** | [PREVIOUS DOCUMENT, IF APPLICABLE] |

### Version History

| Version | Date | Description of Changes | Author | Approved By |
|---|---|---|---|---|
| 1.0 | [DATE] | Initial release | [AUTHOR] | [APPROVER] |

### Distribution List

| Role/Department | Name | Date Distributed |
|---|---|---|
| [ROLE/DEPT] | [NAME] | [DATE] |
| Quality Assurance | [NAME] | [DATE] |
| Regulatory Affairs | [NAME] | [DATE] |

## 1. Introduction

### 1.1 Purpose

This Change Control Management Template provides a standardized format for documenting, evaluating, implementing, and reviewing changes to products, processes, systems, facilities, equipment, and documentation that may impact product quality, safety, efficacy, or regulatory compliance in healthcare and pharmaceutical environments.

### 1.2 Scope

This template applies to proposed changes that may affect:
- Product quality attributes, safety, or efficacy
- Manufacturing processes and equipment
- Facilities, utilities, and supporting systems
- Computer systems and software
- Raw materials, components, and suppliers
- Quality control methods and specifications
- Packaging components and labeling
- Standard operating procedures and documentation
- Regulatory submissions and commitments

### 1.3 Regulatory Framework

This template has been developed in accordance with the following regulatory requirements:
- ICH Q10 Pharmaceutical Quality System
- FDA Guidance for Industry: Changes to an Approved NDA or ANDA
- EU GMP Chapter 1: Pharmaceutical Quality System
- 21 CFR Parts 210 and 211 (cGMP for Finished Pharmaceuticals)
- 21 CFR Part 820 (Quality System Regulation for Medical Devices)
- EU Medical Device Regulation (MDR) 2017/745
- Other applicable regional requirements

## 2. Change Request Details

### 2.1 Change Identification

| Field | Information |
|---|---|
| **Change Control Number** | CC-[YEAR]-[SEQUENTIAL NUMBER] |
| **Change Initiator** | [NAME, TITLE, DEPARTMENT] |
| **Date Submitted** | [SUBMISSION DATE] |
| **Change Title** | [BRIEF DESCRIPTIVE TITLE] |
| **Products/Systems Affected** | [LIST ALL AFFECTED PRODUCTS/SYSTEMS] |

### 2.2 Change Description

*Provide a clear, comprehensive description of the proposed change, including:*

**Current State:**
[Describe the current state of the product, process, system, etc. in detail]

**Proposed Change:**
[Describe the proposed change in detail, including technical specifications, parameters, etc.]

### 2.3 Change Justification

*Explain why this change is necessary, including:*

- Primary reason for change: [SELECT: Improvement, Correction, Compliance, Business need, Other]
- Detailed justification:
  [Provide comprehensive justification with supporting data/references where applicable]
- Benefits expected from this change:
  [List anticipated benefits]
- Consequences of not implementing this change:
  [Describe potential negative outcomes if change is not implemented]

### 2.4 Change Category and Priority

**Change Category:** [SELECT ALL THAT APPLY]
- [ ] Product (formulation, specifications, materials)
- [ ] Process (manufacturing, production methods, in-process controls)
- [ ] Equipment/Facility (manufacturing equipment, facility infrastructure)
- [ ] Computer System (software, hardware, IT infrastructure)
- [ ] Documentation (SOPs, specifications, work instructions)
- [ ] Materials/Components (raw materials, components, suppliers)
- [ ] Quality Control (test methods, acceptance criteria)
- [ ] Other: [SPECIFY]

**Change Classification:**
- [ ] Critical: Significant potential impact on product quality, safety, efficacy, or regulatory status
- [ ] Major: Moderate potential impact on product quality, safety, efficacy, or regulatory status
- [ ] Minor: Minimal potential impact on product quality, safety, efficacy, or regulatory status

**Priority Level:**
- [ ] Emergency: Immediate action required to address safety or compliance issue
- [ ] Urgent: Expedited review and implementation needed
- [ ] Routine: Standard review and implementation timeline acceptable

## 3. Impact Assessment

### 3.1 Quality Impact Assessment

| Aspect | Impact (None/Low/Medium/High) | Description of Impact |
|---|---|---|
| Product identity | [IMPACT] | [DESCRIPTION] |
| Product strength/potency | [IMPACT] | [DESCRIPTION] |
| Product quality attributes | [IMPACT] | [DESCRIPTION] |
| Product stability | [IMPACT] | [DESCRIPTION] |
| Bioavailability/bioequivalence | [IMPACT] | [DESCRIPTION] |
| Sterility assurance (if applicable) | [IMPACT] | [DESCRIPTION] |

### 3.2 Regulatory Impact Assessment

| Regulatory Aspect | Impact (None/Low/Medium/High) | Description of Impact |
|---|---|---|
| Marketing authorizations | [IMPACT] | [DESCRIPTION] |
| Regulatory filings | [IMPACT] | [DESCRIPTION] |
| Submission type required | [IMPACT] | [DESCRIPTION] |
| Implementation timing constraints | [IMPACT] | [DESCRIPTION] |
| Labeling impact | [IMPACT] | [DESCRIPTION] |
| Regional regulatory requirements | [IMPACT] | [DESCRIPTION] |

**Regulatory Classification:**
- [ ] Prior Approval Supplement (PAS) required
- [ ] Changes Being Effected (CBE)
- [ ] Changes Being Effected in 30 Days (CBE-30)
- [ ] Annual Reportable Change
- [ ] Not reportable
- [ ] Other: [SPECIFY]

### 3.3 Validation Impact Assessment

| Validation Aspect | Impact (None/Low/Medium/High) | Description of Impact |
|---|---|---|
| Process validation | [IMPACT] | [DESCRIPTION] |
| Equipment qualification | [IMPACT] | [DESCRIPTION] |
| Computer system validation | [IMPACT] | [DESCRIPTION] |
| Cleaning validation | [IMPACT] | [DESCRIPTION] |
| Method validation/verification | [IMPACT] | [DESCRIPTION] |
| Facility qualification | [IMPACT] | [DESCRIPTION] |

### 3.4 Documentation Impact Assessment

| Documentation Aspect | Impact (None/Low/Medium/High) | Documents Requiring Update |
|---|---|---|
| Specifications | [IMPACT] | [LIST DOCUMENTS] |
| Batch records | [IMPACT] | [LIST DOCUMENTS] |
| Standard operating procedures | [IMPACT] | [LIST DOCUMENTS] |
| Validation documentation | [IMPACT] | [LIST DOCUMENTS] |
| Training materials | [IMPACT] | [LIST DOCUMENTS] |
| Other | [IMPACT] | [LIST DOCUMENTS] |

## 4. Risk Assessment

### 4.1 Risk Identification

| Potential Risk | Risk Description |
|---|---|
| [RISK 1] | [DESCRIPTION] |
| [RISK 2] | [DESCRIPTION] |
| [RISK 3] | [DESCRIPTION] |
| [RISK 4] | [DESCRIPTION] |
| [RISK 5] | [DESCRIPTION] |

### 4.2 Risk Evaluation

| Risk | Probability (Low/Medium/High) | Severity (Low/Medium/High) | Risk Level (Low/Medium/High) |
|---|---|---|---|
| [RISK 1] | [PROBABILITY] | [SEVERITY] | [RISK LEVEL] |
| [RISK 2] | [PROBABILITY] | [SEVERITY] | [RISK LEVEL] |
| [RISK 3] | [PROBABILITY] | [SEVERITY] | [RISK LEVEL] |
| [RISK 4] | [PROBABILITY] | [SEVERITY] | [RISK LEVEL] |
| [RISK 5] | [PROBABILITY] | [SEVERITY] | [RISK LEVEL] |

### 4.3 Risk Control Measures

| Risk | Risk Control Measure | Responsible Person | Implementation Timeline |
|---|---|---|---|
| [RISK 1] | [CONTROL MEASURE] | [RESPONSIBLE PERSON] | [TIMELINE] |
| [RISK 2] | [CONTROL MEASURE] | [RESPONSIBLE PERSON] | [TIMELINE] |
| [RISK 3] | [CONTROL MEASURE] | [RESPONSIBLE PERSON] | [TIMELINE] |
| [RISK 4] | [CONTROL MEASURE] | [RESPONSIBLE PERSON] | [TIMELINE] |
| [RISK 5] | [CONTROL MEASURE] | [RESPONSIBLE PERSON] | [TIMELINE] |

## 5. Implementation Plan

### 5.1 Resource Requirements

| Resource Type | Description | Availability |
|---|---|---|
| Personnel | [DESCRIBE PERSONNEL REQUIREMENTS] | [AVAILABILITY STATUS] |
| Equipment | [DESCRIBE EQUIPMENT REQUIREMENTS] | [AVAILABILITY STATUS] |
| Materials | [DESCRIBE MATERIAL REQUIREMENTS] | [AVAILABILITY STATUS] |
| Budget | [DESCRIBE BUDGET REQUIREMENTS] | [AVAILABILITY STATUS] |
| Other | [DESCRIBE OTHER REQUIREMENTS] | [AVAILABILITY STATUS] |

### 5.2 Implementation Timeline

| Phase | Activity | Start Date | End Date | Responsible Person | Status |
|---|---|---|---|---|---|
| Preparation | [ACTIVITY] | [DATE] | [DATE] | [RESPONSIBLE PERSON] | [STATUS] |
| Implementation | [ACTIVITY] | [DATE] | [DATE] | [RESPONSIBLE PERSON] | [STATUS] |
| Verification | [ACTIVITY] | [DATE] | [DATE] | [RESPONSIBLE PERSON] | [STATUS] |
| Documentation | [ACTIVITY] | [DATE] | [DATE] | [RESPONSIBLE PERSON] | [STATUS] |
| Training | [ACTIVITY] | [DATE] | [DATE] | [RESPONSIBLE PERSON] | [STATUS] |
| Close-out | [ACTIVITY] | [DATE] | [DATE] | [RESPONSIBLE PERSON] | [STATUS] |

### 5.3 Validation Requirements

| Validation Activity | Validation Protocol Reference | Responsible Person | Timeline |
|---|---|---|---|
| [VALIDATION ACTIVITY] | [PROTOCOL REFERENCE] | [RESPONSIBLE PERSON] | [TIMELINE] |
| [VALIDATION ACTIVITY] | [PROTOCOL REFERENCE] | [RESPONSIBLE PERSON] | [TIMELINE] |
| [VALIDATION ACTIVITY] | [PROTOCOL REFERENCE] | [RESPONSIBLE PERSON] | [TIMELINE] |

**Validation Strategy Summary:**
[Provide a brief description of the validation approach, including sampling plans, acceptance criteria, etc.]

## 6. Review and Approval Process

### 6.1 Technical Review

| Technical Area | Reviewer | Comments | Date | Recommendation |
|---|---|---|---|---|
| [AREA] | [REVIEWER] | [COMMENTS] | [DATE] | [APPROVE/REJECT/MODIFY] |
| [AREA] | [REVIEWER] | [COMMENTS] | [DATE] | [APPROVE/REJECT/MODIFY] |
| [AREA] | [REVIEWER] | [COMMENTS] | [DATE] | [APPROVE/REJECT/MODIFY] |

### 6.2 Quality Review

| Quality Area | Reviewer | Comments | Date | Recommendation |
|---|---|---|---|---|
| Quality Assurance | [REVIEWER] | [COMMENTS] | [DATE] | [APPROVE/REJECT/MODIFY] |
| Quality Control | [REVIEWER] | [COMMENTS] | [DATE] | [APPROVE/REJECT/MODIFY] |
| Validation | [REVIEWER] | [COMMENTS] | [DATE] | [APPROVE/REJECT/MODIFY] |

### 6.3 Regulatory Review

| Regulatory Area | Reviewer | Comments | Date | Recommendation |
|---|---|---|---|---|
| Regulatory Affairs | [REVIEWER] | [COMMENTS] | [DATE] | [APPROVE/REJECT/MODIFY] |

### 6.4 Change Control Board Decision

| Decision | Date | Comments |
|---|---|---|
| [ ] Approved as submitted | [DATE] | [COMMENTS] |
| [ ] Approved with conditions | [DATE] | [COMMENTS] |
| [ ] Rejected | [DATE] | [COMMENTS] |
| [ ] Deferred | [DATE] | [COMMENTS] |

**Conditions for Approval (if applicable):**
[List all conditions that must be met for this change to be implemented]

### 6.5 Final Approval Signatures

| Role | Name | Signature | Date |
|---|---|---|---|
| Change Control Coordinator | [NAME] | _________________ | [DATE] |
| Quality Assurance | [NAME] | _________________ | [DATE] |
| Department Head | [NAME] | _________________ | [DATE] |
| Regulatory Affairs (if applicable) | [NAME] | _________________ | [DATE] |
| Qualified Person (if applicable) | [NAME] | _________________ | [DATE] |
| Site Head/Senior Management (if required) | [NAME] | _________________ | [DATE] |

## 7. Post-Implementation Review

### 7.1 Implementation Verification

| Verification Aspect | Verification Method | Results | Verified By | Date | Status |
|---|---|---|---|---|---|
| Change implemented as approved | [METHOD] | [RESULTS] | [VERIFIER] | [DATE] | [PASS/FAIL] |
| All documentation updated | [METHOD] | [RESULTS] | [VERIFIER] | [DATE] | [PASS/FAIL] |
| Training completed | [METHOD] | [RESULTS] | [VERIFIER] | [DATE] | [PASS/FAIL] |
| Validation completed | [METHOD] | [RESULTS] | [VERIFIER] | [DATE] | [PASS/FAIL] |

### 7.2 Effectiveness Review

| Effectiveness Criteria | Measurement Method | Results | Evaluated By | Date | Status |
|---|---|---|---|---|---|
| [CRITERION 1] | [METHOD] | [RESULTS] | [EVALUATOR] | [DATE] | [EFFECTIVE/NOT EFFECTIVE] |
| [CRITERION 2] | [METHOD] | [RESULTS] | [EVALUATOR] | [DATE] | [EFFECTIVE/NOT EFFECTIVE] |
| [CRITERION 3] | [METHOD] | [RESULTS] | [EVALUATOR] | [DATE] | [EFFECTIVE/NOT EFFECTIVE] |

**Overall Effectiveness Assessment:**
[Provide a summary assessment of the overall effectiveness of the change]

### 7.3 Lessons Learned

**What Went Well:**
[Document aspects of the change that were executed effectively]

**What Could Be Improved:**
[Document aspects of the change that could be improved in future changes]

**Recommendations for Future Changes:**
[Document recommendations for improving the change management process]

## 8. Change Control Form

### Change Control Form Template

```
CHANGE CONTROL FORM

CHANGE CONTROL NUMBER: CC-[YEAR]-[NUMBER]                    DATE SUBMITTED: [DATE]

1. CHANGE INITIATOR INFORMATION
   Name: _______________________  Title: _______________________
   Department: __________________  Contact: ____________________

2. CHANGE DETAILS
   Change Title: ______________________________________________
   
   Products/Systems Affected: ___________________________________
   
   Current State:
   _________________________________________________________
   _________________________________________________________
   
   Proposed Change:
   _________________________________________________________
   _________________________________________________________
   
   Justification for Change:
   _________________________________________________________
   _________________________________________________________
   
3. CHANGE CATEGORIZATION
   Change Category:
   □ Product  □ Process  □ Equipment/Facility  □ Computer System
   □ Documentation  □ Materials/Components  □ Quality Control  □ Other
   
   Change Classification:
   □ Critical  □ Major  □ Minor
   
   Priority Level:
   □ Emergency  □ Urgent  □ Routine
   
4. PRELIMINARY IMPACT ASSESSMENT
                       None   Low   Medium   High
   Quality Impact:      □      □      □       □
   Regulatory Impact:   □      □      □       □
   Validation Impact:   □      □      □       □
   Documentation Impact:□      □      □       □
   
   Initial Risk Assessment:
   _________________________________________________________
   _________________________________________________________
   
5. SUPPORTING DOCUMENTATION
   □ Risk Assessment  □ Validation Plan  □ Technical Assessment
   □ Regulatory Assessment  □ Other: ________________________
   
6. REVIEW AND ROUTING
   Initial Review By: _________________  Date: ______________
   
   Route to:
   □ Quality Assurance  □ Regulatory Affairs  □ Manufacturing
   □ Engineering  □ Validation  □ Other: ___________________
   
7. APPROVALS
   Department Review:
   Reviewer: ___________________  Date: ________  □ Approve  □ Reject
   Comments: ________________________________________________
   
   Quality Assurance:
   Reviewer: ___________________  Date: ________  □ Approve  □ Reject
   Comments: ________________________________________________
   
   Regulatory Affairs (if applicable):
   Reviewer: ___________________  Date: ________  □ Approve  □ Reject
   Comments: ________________________________________________
   
   Change Control Board Decision:
   □ Approved  □ Approved with Conditions  □ Rejected  □ Deferred
   Date: ______________
   
   Conditions/Comments:
   _________________________________________________________
   _________________________________________________________
   
8. IMPLEMENTATION
   Implementation Start Date: ____________  
   Planned Completion Date: ____________
   
   Implemented By: _________________  Date: ______________
   
   Verification of Implementation:
   Verified By: _________________  Date: ______________
   
9. CHANGE CLOSURE
   All requirements met:  □ Yes  □ No
   
   Change Closed By: _________________  Date: ______________
```

## 9. Practical Examples for Different Types of Changes

### 9.1 Example: Critical Process Change

**Change Description:** Change in the sterilization cycle parameters for aseptic processing area from [current parameters] to [proposed parameters].

**Impact Assessment:**
- Quality Impact: High - Could affect product sterility assurance
- Regulatory Impact: High - Requires notification to regulatory authorities
- Validation Impact: High - Requires revalidation of sterilization process

**Risk Control Measures:**
1. Conduct engineering studies to verify equipment capability
2. Perform microbiological qualification studies
3. Execute three consecutive validation runs before implementation
4. Implement enhanced environmental monitoring during initial implementation

**Implementation Timeline:**
- Engineering assessment: 2 weeks
- Protocol development: 2 weeks
- Validation execution: 4 weeks
- Data review and approval: 2 weeks
- Implementation: After regulatory notification/approval

### 9.2 Example: Major Equipment Change

**Change Description:** Replacement of tablet compression machine from [current model] to [new model] with equivalent specifications.

**Impact Assessment:**
- Quality Impact: Medium - Could affect tablet physical attributes
- Regulatory Impact: Medium - Annual reportable change
- Validation Impact: Medium - Requires equipment qualification and process verification

**Risk Control Measures:**
1. Conduct comparative analysis of equipment specifications
2. Perform Installation Qualification (IQ) and Operational Qualification (OQ)
3. Execute Process Performance Qualification (PPQ) on three batches
4. Implement in-process monitoring of critical quality attributes

**Implementation Timeline:**
- Equipment procurement: 12 weeks
- Installation and IQ/OQ: 4 weeks
- Process verification: 6 weeks
- Implementation: After successful validation

### 9.3 Example: Minor Documentation Change

**Change Description:** Update to batch record template to improve clarity of in-process control documentation.

**Impact Assessment:**
- Quality Impact: Low - Improves documentation clarity
- Regulatory Impact: None - No impact on registered information
- Validation Impact: None - No impact on validated processes

**Risk Control Measures:**
1. Review by affected departments
2. Operator training on new format
3. Transition period with verification of correct completion

**Implementation Timeline:**
- Document update: 1 week
- Review and approval: 2 weeks
- Training: 1 week
- Implementation: Immediately after training

## 10. References

1. ICH Q10: Pharmaceutical Quality System
2. ICH Q9: Quality Risk Management
3. FDA Guidance for Industry: Changes to an Approved NDA or ANDA
4. EU Guidelines for Good Manufacturing Practice, Chapter 1
5. PIC/S Guide to Good Manufacturing Practice for Medicinal Products
6. FDA 21 CFR Parts 210 and 211: Current Good Manufacturing Practice
7. FDA 21 CFR Part 820: Quality System Regulation
8. EU Medical Device Regulation (MDR) 2017/745
9. ISPE GAMP 5: A Risk-Based Approach to Compliant GxP Computerized Systems
10. WHO Technical Report Series No. 996, 2016, Annex 4 (GMP)

---

*End of Change Control Management Template*
